MIF is a pleiotropic inflammatory cytokine, for which the mechanism of action is related to AF progression, promoting fibrosis development through the activation of the TGF-β signaling pathway, and was described to be affected by miR-451a downregulation. The gene discussed is TGFB1; the disease is atrial fibrillation.